Cornerstone Retirement Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,758
Closed -$240K 36
2023
Q2
$240K Hold
3,758
0.07% 23
2023
Q1
$260K Buy
3,758
+400
+12% +$28.2K 0.08% 17
2022
Q4
$242K Buy
+3,358
New +$253K 0.07% 9

Other funds holding BMY

Cornerstone Retirement Group's BMY Position: Q3 2023 in Review

Cornerstone Retirement Group sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,758 shares — an estimated $240K sold.

Cornerstone Retirement Group first reported a position in BMY in Q4 2022 and held it in 3 quarters. The position peaked at $260K in Q1 2023. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Cornerstone Retirement Group reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Cornerstone Retirement Group sold 3,758 Bristol-Myers Squibb shares in Q3 2023, an estimated $240K.
  • Cornerstone Retirement Group first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 3 quarters.
  • Cornerstone Retirement Group's Bristol-Myers Squibb position peaked at $260K in Q1 2023.
  • 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Cornerstone Retirement Group's 13F filing for Q3 2023, filed 26 Oct 2023.